Castle Biosciences (CSTL) Other Non-Current Assets (2018 - 2026)

Castle Biosciences (CSTL) has 9 years of Other Non-Current Assets data on file, last reported at $4.3 million in Q1 2026.

• Quarterly Other Non-Current Assets rose 237.91% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 million (up 237.91% YoY) and the FY2025 annual result came in at $3.8 million, up 206.92% from the prior year.
• Other Non-Current Assets rose to $4.3 million in Q1 2026 per CSTL's latest filing, from $3.8 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $4.3 million in Q1 2026, with the low at $792000.0 in Q1 2023.
• Average Other Non-Current Assets over 5 years is $1.8 million, with a median of $1.3 million recorded in 2025.
• Year-over-year, Other Non-Current Assets plunged 70.66% in 2023 and soared 237.91% in 2026.
• Castle Biosciences' Other Non-Current Assets stood at $1.1 million in 2022, then rose by 29.73% to $1.4 million in 2023, then decreased by 14.72% to $1.2 million in 2024, then surged by 206.92% to $3.8 million in 2025, then rose by 13.5% to $4.3 million in 2026.
• Business Quant data shows CSTL's Other Non-Current Assets at $4.3 million in Q1 2026, $3.8 million in Q4 2025, and $1.3 million in Q3 2025.